当前位置：
主页产品
详情

3,5-Dichloro-4-hydroxybenzoic acid | CAS:3336-41-2

3,5-Dichloro-4-hydroxybenzoic acid

名称：3,5-二氯-4-羟基苯甲酸; 3,5-二氯对羟基苯甲酸 | 3,5-Dichloro-4-hydroxybenzoic acid
CAS号：3336-41-2
别名：
分子式：C₇H₄Cl₂O₃
分子量：207.01
EINESC号：222-071-9

产品描述

物理化学性质

熔点	260-265 ºC

安全数据

危险品标志	Xi
危险类别码	R36/37/38
安全说明书	S26;S37/39

SDS

来源	SDS样本
Alfa-Aesar	浏览或下载
Sigma-Aldrich	浏览或下载
TCI	浏览或下载

产品合成路线

名称	CAS号

文章

同行评议文献

PKCα Deficiency in Mice Is Associated with Pulmonary Vascular Hyperresponsiveness to Thromboxane A2 and Increased Thromboxane Receptor Expression.Christoph Tabeling et al.Journal of vascular research, 52(4), 279-288 (2016-02-20) New anti-tuberculosis agents amongst known drugs.Kathryn E A Lougheed et al.Tuberculosis (Edinburgh, Scotland), 89(5), 364-370 (2009-08-25) Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.Cecilia K Zetterström et al.Journal of leukocyte biology, 83(1), 31-38 (2007-10-05) Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin.Farivash Darabi et al.Journal of inorganic biochemistry, 149, 102-107 (2015-04-14) aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability.Meghan Riddell et al.Nature communications, 9(1), 5357-5357 (2018-12-19)

备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称	CAS号

产品描述

物理化学性质

安全数据

SDS

相关产品

相关资讯